The present invention provides a compound selected from the group consisting of dichloroacetate mono and diesters of honokiol, valproate mono and diesters of honokiol, and C1-6 alkyl phosphate mono and di-esters of honokiol. The compounds can be provided as pharmaceutical compositions and can be used for the treatment and/or prevention of conditions such as inflammatory disorders and cancer.